Latest Insider Transactions at Ekso Bionics Holdings, Inc. (EKSO)
This section provides a real-time view of insider transactions for Ekso Bionics Holdings, Inc. (EKSO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of EKSO BIONICS HOLDINGS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of EKSO BIONICS HOLDINGS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2022
|
Kecheng Li Director |
BUY
Grant, award, or other acquisition
|
Direct |
51,721
+39.53%
|
-
|
|
Jun 09
2022
|
Mary Ann Cloyd Director |
BUY
Grant, award, or other acquisition
|
Direct |
51,721
+40.85%
|
-
|
|
May 25
2022
|
Scott G. Davis President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+44.52%
|
-
|
|
May 24
2022
|
Steven Sherman Executive Chair |
SELL
Open market or private sale
|
Direct |
6,597
-1.02%
|
$6,597
$1.76 P/Share
|
|
May 21
2022
|
Steven Sherman Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
15,599
+2.36%
|
-
|
|
Apr 28
2022
|
Steven Sherman Executive Chair |
SELL
Open market or private sale
|
Direct |
6,862
-1.08%
|
$13,724
$2.41 P/Share
|
|
Apr 21
2022
|
Steven Sherman Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
15,599
+2.4%
|
-
|
|
Apr 20
2022
|
Scott G. Davis President & COO |
SELL
Open market or private sale
|
Direct |
4,043
-5.19%
|
$8,086
$2.62 P/Share
|
|
Apr 07
2022
|
Jason C Jones Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+27.53%
|
-
|
|
Mar 24
2022
|
Steven Sherman Executive Chair |
SELL
Open market or private sale
|
Direct |
6,389
-1.02%
|
$12,778
$2.94 P/Share
|
|
Mar 22
2022
|
Jason C Jones Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,265
-3.85%
|
$6,530
$2.82 P/Share
|
|
Mar 22
2022
|
John Glenn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,462
-8.97%
|
$6,924
$2.82 P/Share
|
|
Mar 21
2022
|
Steven Sherman Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
15,599
+2.43%
|
-
|
|
Mar 15
2022
|
Steven Sherman Executive Chair |
SELL
Open market or private sale
|
Direct |
5,965
-0.97%
|
$11,930
$2.6 P/Share
|
|
Mar 08
2022
|
Steven Sherman Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
15,599
+2.47%
|
-
|
|
Feb 17
2022
|
Jason C Jones Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
3,346
+42.69%
|
-
|
|
Feb 17
2022
|
John Glenn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,596
+27.44%
|
-
|
|
Feb 17
2022
|
Jason C Jones Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,760
+13.95%
|
-
|
|
Feb 17
2022
|
William R Shaw Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,943
+15.62%
|
-
|
|
Feb 17
2022
|
Scott G. Davis President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
41,158
+34.58%
|
-
|
|
Dec 25
2021
|
Corinna Lathan Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+49.76%
|
-
|
|
Aug 31
2021
|
Jack Peurach President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+33.91%
|
-
|
|
Aug 03
2021
|
William R Shaw Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+38.76%
|
-
|
|
Aug 03
2021
|
Jason C Jones Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+41.27%
|
-
|
|
Jun 10
2021
|
Rhonda A. Wallen Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,265
+44.08%
|
-
|
|
Jun 10
2021
|
Steven Sherman Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct |
18,265
+2.71%
|
-
|
|
Jun 10
2021
|
Stanley Stern Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,265
+39.91%
|
-
|
|
Jun 10
2021
|
Kecheng Li Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,265
+39.99%
|
-
|
|
Jun 10
2021
|
Mary Ann Cloyd Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,265
+44.08%
|
-
|
|
Mar 03
2021
|
Jack Peurach President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
45,725
+34.64%
|
-
|
|
Mar 03
2021
|
John Glenn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,015
+35.17%
|
-
|
|
Mar 03
2021
|
William R Shaw Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+35.56%
|
-
|
|
Mar 03
2021
|
Jason C Jones Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,270
+36.72%
|
-
|
|
Feb 18
2021
|
Rhonda A. Wallen Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,910
+50.0%
|
-
|
|
Feb 18
2021
|
Mary Ann Cloyd Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,910
+50.0%
|
-
|
|
Jan 28
2021
|
Jason C Jones Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
1,145
+50.0%
|
-
|
|
Nov 10
2020
|
Theodore T Wang Director |
SELL
Other acquisition or disposition
|
Indirect |
744,572
-96.15%
|
-
|